According to the nucleotide sequence of egg drop syndrome virus(EDSV)AV-127 strain (a foreign standard isolate)from the GenBank,a pair of oligonucleotide primers was designed and synthesizedWith use of polymerase ch...According to the nucleotide sequence of egg drop syndrome virus(EDSV)AV-127 strain (a foreign standard isolate)from the GenBank,a pair of oligonucleotide primers was designed and synthesizedWith use of polymerase chain reaction(PCR),the hexon-encoding gene fragment was amplified from the genome of EDSV SG9301 strain that was isolated from Sichuan Province of China and the amplified fragment was directly inserted into pMD-T vectorThe recombinant plasmid harboring the hexon-encoding gene was identified by digestion of restriction endonucleases and PCRThen,a positive clone was sequencedThe result showed that the recombinant plasmid contained the complete sequence of the hexon-encoding gene and the hexon-encoding gene was 2733 base pair long which encoded 910 amino acids, identical with AV-127 strain and AAV-2 strain (an attenuated strain)Comparison with AV-127 strain indicated that there was 9985% homology at the nucleotide levelThe homology of the deduced amino acid sequence with AV-127 strain and AAv-2 strain was over 98%,which indicated that the hexon protein was conservativeBut comparatively,the homology of the hexon protein of SG9301 strain with AV-127 strain was higher(9978%),the homology of the hexon protein of AAV-2 strain with AV-127 strain and SG9301 strain were 9868% and 9846% respectivelyComparison of nucleotides and amino acids suggested that the biological character is consistent with the homologies of nucleotide and amino acid of the hexon(Namely,the homology of the hexon of virulence strain with virulence strain was higher than that of virulence strain with attenuated strain),the hexon was one of the most conserved viral proteins among EDSV展开更多
Little information is available on the prevalence of drug-resistance mutations in patients harboring the human immunodeficiency virus type 1(HIV-1) circulating recombinant form(CRF)07_BC variant in Sichuan, China. Thi...Little information is available on the prevalence of drug-resistance mutations in patients harboring the human immunodeficiency virus type 1(HIV-1) circulating recombinant form(CRF)07_BC variant in Sichuan, China. This study examined 375 plasma samples from patients with HIV-1 who were infected with the CRF07_BC strain, including 104 drug-naive participants and 271 in whom antiretroviral therapy(ART) had failed. Only one participant in the drug-naive group had a drug-resistance mutation(M46L), compared with 31.73% of those in whom ART had failed. Further analysis showed that 19.56% of strains contained mutations conferring resistance to non-nucleoside reverse transcriptase inhibitors(NNRTIs) alone, 0.74% were resistant to nucleoside reverse transcriptase inhibitors(NRTIs) alone, and 11.44% were dual-resistant to both NRTIs and NNRTIs. The most common mutation in the ART-failure group was M184V(35.88%), K103N(45.01%), Y181C(17.33%), and G190S/A(15.88%). The percentages of HIV-1 strains resistant to lamivudine, emtricitabine, efavirenz, etravirine, and nevirapine were 10.70%, 10.70%, 28.04%, 7.75%, and 26.20%, respectively. To explore site variants possibly related to drug resistance, variations in the ancestor/consensus CRF07_BC sequences from the therapy-naive and ART-failure groups were compared, and seven mutations at six positions were identified as being significantly differently distributed between the two groups(p<0.05). Detailed sequence data will provide information on CRF07_BC genetic characterizations, and improve our understanding of antiretroviral susceptibility and the evolution of drug-resistance mutations. This will be valuable in developing and implementing local public-health approaches for HIV drug-resistance prevention and treatment.展开更多
文摘According to the nucleotide sequence of egg drop syndrome virus(EDSV)AV-127 strain (a foreign standard isolate)from the GenBank,a pair of oligonucleotide primers was designed and synthesizedWith use of polymerase chain reaction(PCR),the hexon-encoding gene fragment was amplified from the genome of EDSV SG9301 strain that was isolated from Sichuan Province of China and the amplified fragment was directly inserted into pMD-T vectorThe recombinant plasmid harboring the hexon-encoding gene was identified by digestion of restriction endonucleases and PCRThen,a positive clone was sequencedThe result showed that the recombinant plasmid contained the complete sequence of the hexon-encoding gene and the hexon-encoding gene was 2733 base pair long which encoded 910 amino acids, identical with AV-127 strain and AAV-2 strain (an attenuated strain)Comparison with AV-127 strain indicated that there was 9985% homology at the nucleotide levelThe homology of the deduced amino acid sequence with AV-127 strain and AAv-2 strain was over 98%,which indicated that the hexon protein was conservativeBut comparatively,the homology of the hexon protein of SG9301 strain with AV-127 strain was higher(9978%),the homology of the hexon protein of AAV-2 strain with AV-127 strain and SG9301 strain were 9868% and 9846% respectivelyComparison of nucleotides and amino acids suggested that the biological character is consistent with the homologies of nucleotide and amino acid of the hexon(Namely,the homology of the hexon of virulence strain with virulence strain was higher than that of virulence strain with attenuated strain),the hexon was one of the most conserved viral proteins among EDSV
基金supported by the Chinese Government AIDS Program (grant number 2008ZX001-016)the China 4th Global Fund AIDS Program (grant number CHN-405-G05-H)a Sichuan Provincial Health Department research project (number 120154)
文摘Little information is available on the prevalence of drug-resistance mutations in patients harboring the human immunodeficiency virus type 1(HIV-1) circulating recombinant form(CRF)07_BC variant in Sichuan, China. This study examined 375 plasma samples from patients with HIV-1 who were infected with the CRF07_BC strain, including 104 drug-naive participants and 271 in whom antiretroviral therapy(ART) had failed. Only one participant in the drug-naive group had a drug-resistance mutation(M46L), compared with 31.73% of those in whom ART had failed. Further analysis showed that 19.56% of strains contained mutations conferring resistance to non-nucleoside reverse transcriptase inhibitors(NNRTIs) alone, 0.74% were resistant to nucleoside reverse transcriptase inhibitors(NRTIs) alone, and 11.44% were dual-resistant to both NRTIs and NNRTIs. The most common mutation in the ART-failure group was M184V(35.88%), K103N(45.01%), Y181C(17.33%), and G190S/A(15.88%). The percentages of HIV-1 strains resistant to lamivudine, emtricitabine, efavirenz, etravirine, and nevirapine were 10.70%, 10.70%, 28.04%, 7.75%, and 26.20%, respectively. To explore site variants possibly related to drug resistance, variations in the ancestor/consensus CRF07_BC sequences from the therapy-naive and ART-failure groups were compared, and seven mutations at six positions were identified as being significantly differently distributed between the two groups(p<0.05). Detailed sequence data will provide information on CRF07_BC genetic characterizations, and improve our understanding of antiretroviral susceptibility and the evolution of drug-resistance mutations. This will be valuable in developing and implementing local public-health approaches for HIV drug-resistance prevention and treatment.
